Cost-effectiveness of counseling and testing and partner notification: a decision analysis

被引:62
作者
Varghese, B [1 ]
Peterman, TA [1 ]
Holtgrave, DR [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA
关键词
HIV prevention programs; counseling and testing; partner notification; cost-effectiveness;
D O I
10.1097/00002030-199909100-00019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Counseling and testing and partner notification are effective HIV prevention strategies, but they can be resource intensive. This paper evaluates the cost-effectiveness of partner notification and counseling and testing offered in HIV and sexually transmitted disease (STD) clinics in preventing future HIV infections in the United States of America. Methods: Decision trees were developed From both societal and provider perspectives. The counseling and testing and partner notification models incorporate estimates of HIV prevalence, return rates for counseling, risk of HIV transmission within 1 year, and the effectiveness of counseling. Cost estimates for counseling and testing and partner notification programs and lifetime treatment cost of HIV for the United States of America were obtained from published literature. Extensive sensitivity analyses of model parameters were conducted. Results: For a cohort of 10 000 individuals at a clinic with an HIV seroprevalence of 1.5%, we estimate that counseling and testing prevents eight HIV infections and saves society almost $1 000 000, We estimate that partner notification for the 113 infected persons identified by counseling and testing, prevents another 1.2 HIV infections and saves an additional $181 000. To the provider (HIV and STD clinics), this translates to a cost of $32 000 per case prevented by counseling and testing and an additional $28 000 for partner notification. Model results are most sensitive to assumptions of HIV prevalence, risk of transmission, and treatment cost of HIV. Conclusions: Counseling and testing and partner notification are cost effective in preventing HIV transmission in this setting. This model can be adapted to assess the cost-effectiveness of counseling and testing and partner notification in other settings. 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1745 / 1751
页数:7
相关论文
共 22 条
[2]  
Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44
[3]   Costs of HIV+/AIDS at CD4(+) counts disease stages based on treatment protocols [J].
Gable, CB ;
Tierce, JC ;
Simison, D ;
Ward, D ;
Motte, K .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (04) :413-420
[4]   THE LIFETIME COST OF TREATING A PERSON WITH HIV [J].
HELLINGER, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (04) :474-478
[5]   EVIDENCE FOR THE EFFECTS OF HIV ANTIBODY COUNSELING AND TESTING ON RISK BEHAVIORS [J].
HIGGINS, DL ;
GALAVOTTI, C ;
OREILLY, KR ;
SCHNELL, DJ ;
MOORE, M ;
RUGG, DL ;
JOHNSON, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (17) :2419-2429
[6]  
HOFFMAN RE, 1995, J ACQ IMMUN DEF SYND, V8, P406
[7]  
Holtgrave DR, 1996, ANNU REV PUBL HEALTH, V17, P467
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS COUNSELING, TESTING, REFERRAL, AND PARTNER NOTIFICATION SERVICES - A COST-BENEFIT-ANALYSIS [J].
HOLTGRAVE, DR ;
VALDISERRI, RO ;
GERBER, AR ;
HINMAN, AR .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (10) :1225-1230
[9]   Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs [J].
Holtgrave, DR ;
Pinkerton, SD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 16 (01) :54-62
[10]   Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases - A randomized controlled trial [J].
Kamb, ML ;
Fishbein, M ;
Douglas, JM ;
Rhodes, F ;
Rogers, J ;
Bolan, G ;
Zenilman, J ;
Hoxworth, T ;
Malotte, CK ;
Iatesta, M ;
Kent, C ;
Lentz, A ;
Graziano, S ;
Byers, RH ;
Peterman, TA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (13) :1161-1167